Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tarsus Pharmaceuticals Inc (NQ: TARS )

26.52 +0.44 (+1.69%)
Streaming Delayed Price Updated: 9:34 AM EDT, Jun 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tarsus Pharmaceuticals Inc

< Previous 1 2 Next >
Tarsus Launches “Don’t Freak Out. Get Checked Out.” Campaign During Healthy Vision Month to Encourage Patients with Demodex Blepharitis to Visit Eye Care Providers
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus to Participate at the Bank of America 2023 Healthcare Conference
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Reports Full-Year 2022 Financial Results and Recent Business Achievements
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus to Present at Upcoming Investor Conferences
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Added to NASDAQ Biotechnology Index
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Announces Positive Topline Data from Phase 1b Callisto Trial and Initiates Phase 2a Carpo Human Tick Kill Trial Evaluating TP-05, A Novel, Oral Therapeutic for the Prevention of Lyme Disease
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Reports Third Quarter 2022 Financial Results and Recent Business Achievements
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus to Present Additional Saturn-2 Pivotal Phase 3 Trial Data at the American Academy of Optometry 2022 Annual Meeting
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Announces Transition Plans for Board of Directors
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Appoints Scott Morrison as Board Member and Audit Committee Chair
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Launches “Look at the Lids” Campaign to Encourage Eye Care Professionals to Identify and Diagnose Demodex Blepharitis
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.